Diovan News

Tekturna combo gets US OK - In-PharmaTechnologist.com

... also Novartis' top-selling hypertension med Diovan (valsartan), production capacity for which will increase by 60 tons a year following the expansion. ...

http://www.in-pharmatechnologist.... | Posted: Tue Jan 22 04:52:31 -0500 2008

Charges Knock Novartis Results - TheStreet.com

... high single-digit sales growth for the division by the fourth quarter of 2008 with new product launches and expansions of its Diovan and Gleevec/Glivec. ...

http://www.thestreet.com/s/charge... | Posted: Thu Jan 17 12:54:49 -0500 2008

Novartis: Latest Victim Of US Economy - Forbes

Novartis, which makes drugs like Diovan, used to treat hypertension, and Ritalin, used to treat attention deficit disorder, has been struggling to jump ...

http://www.forbes.com/markets/200... | Posted: Thu Jan 17 17:00:29 -0500 2008

Novartis achieves record results in 2007 - Prdomain Business Register (press release)

The high blood pressure medicine Diovan (USD 5.0 billion, 16% lc) exceeded USD 5 billion for the first time, while the cancer therapy Gleevec/Glivec (USD ...

http://www.prdomain.com/companies... | Posted: Fri Jan 18 05:43:09 -0500 2008

Novartis profits hit by restructuring charge - MSNBC

Pharmaceuticals mainstays Diovan for high blood pressure and Glivec for leukaemia also continued to expand sales sharply, for the first time breaching for ...

http://www.msnbc.msn.com/id/22701... | Posted: Thu Jan 17 05:10:53 -0500 2008

Novartis Fourth-Quarter Net Drops on Job Cut Costs (Update3) - Bloomberg

Sales rose 5.7 percent, the maker of the Diovan heart medicine said. Slowing sales pushed Chief Executive Officer Daniel Vasella to cut 2500 posts over the ...

http://www.bloomberg.com/apps/new... | Posted: Thu Jan 17 03:22:11 -0500 2008

Novartis achieves record results in 2007 underscoring benefits of ... - Market Wire (press release)

The high blood pressure medicine Diovan (USD 5.0 billion, 16% lc) exceeded USD 5 billion for the first time, while the cancer therapy Gleevec/Glivec (USD ...

http://www.marketwire.com/mw/rele... | Posted: Thu Jan 17 01:02:09 -0500 2008

Restructuring Costs, Poor US Pharma Sales Pull Novartis' Q4 Profit ... - RTT News

all 10 news articles

Posted: Thu Jan 17 06:32:43 -0500 2008

Novartis achieves record results in 2007 underscoring benefits of ... - Trading Markets (press release)

The high blood pressure medicine Diovan (USD 5.0 billion, 16% lc) exceeded USD 5 billion for the first time, while the cancer therapy Gleevec/Glivec (USD ...

http://www.tradingmarkets.com/.si... | Posted: Thu Jan 17 01:07:39 -0500 2008